Optimizing delivery systems for RNA therapeutics to improve targeting, uptake, and bioavailability in diverse tissues

Exploring RNA therapeutics in clinical and preventive applications with respiratory viruses as one example

Addressing stability and formulation challenges for systemic and localized administration including respiratory routes

Translating RNA therapeutics from bench to GMP with attention to scale-up, safety, and reproducible manufacturing